Company / Total Assets
Co-Diagnostics, Inc. Total Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$24.7M
FY2025
5-year range
$24.7M / $160.0M
FY2021-FY2025
Trend
-61.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 4 consecutive years, from $160M in FY2021 to $25M in FY2025.
Based on SEC 10-K filings.
$25M in FY2025 with a 5-year CAGR of -19.1%.
Declined from $95M to $25M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -41.4%
- 5-Year CAGR
- -19.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Co-Diagnostics, Inc.'s total assets has declined for 4 consecutive years.
- 5-year CAGR of -19.1%, indicating a declining trend.
- In FY2025, total assets decreased 61.1% year-over-year.
- Peak total assets was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.7M | -61.1% |
| FY2024 | $63.6M | -33.3% |
| FY2023 | $95.3M | -22.6% |
| FY2022 | $123.1M | -23.1% |
| FY2021 | $160.0M | +124.6% |
| FY2020 | $71.2M | +3115.7% |
| FY2019 | $2.2M | +42.6% |
| FY2018 | $1.6M | -66.7% |
| FY2017 | $4.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026